Navigation Links
Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
Date:10/13/2010

rmulated collagen topical gel wound care dressing is currently the subject of a pending FDA 510(k) clearance application for marketing and sales in the United States.  

"These important new findings provide further insight into the significant and rapid healing response that our Excellagen product candidate demonstrated in the Matrix clinical study.  We believe that multiple treatments over a 12-week treatment period provide an opportunity to sustain accelerated healing rates and enhance the wound care management process for patients suffering with non-healing chronic diabetic foot ulcers.  We look forward to the market launch of Excellagen planned for this year, upon clearance by the FDA of our pending 510(k) notification, and to the development of new product extensions based on our custom formulated collagen product platform for additional wound healing applications," stated Christopher J. Reinhard, Cardium's Chairman and Chief Executive Officer.

About Excellagen

Excellagen is a highly-refined fibrillar bovine Type I collagen-based topical gel (2.6% collagen concentration) which has been evaluated in a controlled, double-blind randomized, multi-center Phase 2b clinical study at 23 U.S.-based medical centers for the treatment of chronic non-healing diabetic foot ulcers (the Matrix Study).  If the pending 510(k) notification to the FDA is cleared as submitted, Excellagen would be indicated for the management of wounds, including partial and full thickness wounds, pressure ulcers, diabetic ulcers, chronic vascular ulcers and certain other wounds, such as surgical and trauma wounds.  

Analysis of data from the Matrix Study indicates that the Excellagen product candidate appeared to be both safe and well tolerated, demonstrated improved wound area reductions and wound closure rates at 12 weeks following one or two treatments, and showed a statistically significant acceleration of wound healing during
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015  Verus Healthcare, Inc. ... acquisition of CPAP Care Club in 2012.  Since that ... within the durable medical equipment (DME) industry by 1,000%.  ... for their CPAP supply needs and processes nearly 14,000 ... this company three years ago, the systems and processes ...
(Date:5/4/2015)... , May 4, 2015 ... Market by Scope (Rigid (Laparoscope, Ureteroscope), Flexible (Colonoscope, Gastroscope), ... by Application (Colonoscopy, Laparoscopy, Arthroscopy) - Global Forecasts to ... expected to reach $19.0 Billion by 2019 with a ... to 2019). Browse   127   ...
(Date:5/4/2015)... 2015 /PRNewswire/ - YOLO Medical Inc. , ... distribution of medical and aesthetic devices, proudly announces ... YOLO,s new generation body contouring laser system; LIPOFINA. ... second-generation low-level laser device for body contouring, creating ... patented technology while continuing to push the envelope ...
Breaking Medicine Technology:Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2The Medical Videoscope Market Worth $19.0 Billion by 2019 2The Medical Videoscope Market Worth $19.0 Billion by 2019 3The Medical Videoscope Market Worth $19.0 Billion by 2019 4The Medical Videoscope Market Worth $19.0 Billion by 2019 5YOLO Medical Inc. receives FDA clearance for body contouring laser 2
... 2011 Reportlinker.com announces that a new ... its catalogue: Immunotherapy ... http://www.reportlinker.com/p0284906/Immunotherapy-in-Oncology-Drug-Pipeline-Update-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy ... attractive therapeutic addition, delivering treatment of ...
... Scotland, September 7, 2011 The Astellas European ... Transplantation Grant: Dr Christian Toso of the University ... led by Dr Toso, received the grant of US$ 300,000 ... tailored immuno - suppression after liver transplantation for ...
Cached Medicine Technology:Immunotherapy in Oncology Drug Pipeline Update 2011 2Immunotherapy in Oncology Drug Pipeline Update 2011 3Immunotherapy in Oncology Drug Pipeline Update 2011 4Immunotherapy in Oncology Drug Pipeline Update 2011 5Immunotherapy in Oncology Drug Pipeline Update 2011 6Immunotherapy in Oncology Drug Pipeline Update 2011 7The Astellas European Foundation Winner of Transplantation Grant 2011 Announced 2
(Date:5/4/2015)... 2015 New findings released today from ... (ABTA) show that people diagnosed with a brain tumor ... including clinical trials, at the time of diagnosis, and ... decisions about their course of treatment. The release of ... nationwide brain tumor volunteer network, the ABTA CommYOUnity™, dedicated ...
(Date:5/4/2015)... 2015 Dr. Benjamin Stong of Kalos ... the latest non-surgical double-chin eliminator. Dr. Stong is ... in Atlanta to offer Kybella treatments . The ... specifically under the chin, promising to safely dissolve fat ... patients who sought immediate solutions for their double chin ...
(Date:5/4/2015)... May 04, 2015 In response ... Preventive Services Task Force (USPSTF), Strategic Radiology® (SR®) ... Congress of Obstetricians and Gynecologists (ACOG), the American ... Cure, American Cancer Society (ACS), American College of ... to unanimously recommend regular screening mammography for women ...
(Date:5/4/2015)... “ Food Cost Calculator ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... efficiently calculate food costs. , The restaurant industry is a ... has an estimated 1.8 trillion dollar impact on the US ...
(Date:5/4/2015)... San Diego, CA (PRWEB) May 04, 2015 ... New Cireson Platform to ... Cireson offers customers a choice to consume Microsoft ... cloud or Hyper-V on premise , Company ... focused model , Continuous innovation with expanding ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 3Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 4
... 4 Crdentia Corp. (OTC Bulletin,Board: CRDT), ... services,today announced the appointment of Mr. Randall ... Chief Clinical Officer. In this newly created,position, ... compliance and accreditation, assisting in business,plan development ...
... Online Resource to Support Journal Editors Handling ... of scientific, technical and,medical information products and ... Ethics Resource Kit (PERK),( http://www.elsevier.com/publishingethicskit )., ... in Singapore, Mark,Seeley, Senior Vice President and ...
... 4 Seniors have done their share.,Millions stepped ... insurance and state government have failed to stop,runaway ... rich coverage have,been forced to lapse their policies. ... approval and endorsement., Last week,s Wall Street ...
... nutrient education, WHITE PLAINS, N.Y., March 4 Despite ... to take drastic measures to lose,weight, with one third saying ... lose a few pounds, a recent survey found., Although ... of the time or more often, many do not fully ...
... report they are not getting the sleep they need ... may contribute to their inadequate sleep. The survey, issued ... (ACCP-SI), found that most physicians sleep fewer hours than ... believe their work schedules do not allow for adequate ...
... cellular pathways involved in cancer metastasis , , MONDAY, March ... regulates development of human embryonic stem cells can inhibit ... breast cancers, says a study by researchers at Northwestern ... week,s online issue of the Proceedings of the ...
Cached Medicine News:Health News:Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer 2Health News:Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer 3Health News:Elsevier Launches Publishing Ethics Resource Kit 2Health News:State Governments are Snookering Seniors 2Health News:New Survey Shows 90 Percent of Women Do Not Fully Understand the Calories They Eat 2Health News:New Survey Shows 90 Percent of Women Do Not Fully Understand the Calories They Eat 3Health News:Physicians report they need more sleep 2Health News:Physicians report they need more sleep 3Health News:Embryonic Stem Cell Protein Inhibits Melanoma 2
... Flexible Ureteroscope (DUR-D) incorporates many of ... durable, market leading DUR® series flexible ... device utilizing Gyrus ACMIs proprietary, worlds ... Oxide Semi-Conductor (CMOS) distal sensor technology ...
... new ImmunoCard STAT! EHEC is the first one-step ... Shiga Toxin 1 and 2 produced by Enterohemorrhagic ... on McConkey broth overnight enrichment of fecal specimens ... and 100% specificity., The separate result for Toxin ...
Inquire...
... elegant and sophisticated woman, the ... ophthalmic and sunwear styles. Frames ... of shapes and colors, designed ... and complexions. Many styles feature ...
Medicine Products: